Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT05883540. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT05883540
Lysergic Acid Diethylamide (LSD) in Palliative Care
This study is recruiting. It focuses on anxiety and currently lists participation information in Switzerland.
AnxietyOtherOver 22 Years
Key information made simple
This study is comparing Lysergic Acid Diethylamide Tartrate with control arm for people with depression or anxiety. Participants receive Lysergic Acid Diethylamide Tartrate or control arm and complete study visits and assessments. Some participants may receive control arm instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a hospital, with sites including Spital Uster AG, University Hospital Basel, and University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care in Zurich. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- Hospital / academic medical center
- Main activity
- observational follow-up
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Lysergic Acid Diethylamide (LSD) in Palliative Care
- Condition
- Palliative Care; Pain; Anxiety; Depression; Demoralization; Psychological Distress; Quality of Life; Caregiver Burden; Fear of Death; Existential Distress
- Study status
- Recruiting
- Sponsor / lead affiliation
- University Hospital, Basel, Switzerland
- Location / country
- Switzerland
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT05883540
Why this study may matter
This study may matter because it adds public evidence around anxiety. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Switzerland.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Lysergic Acid Diethylamide (LSD) in Palliative Care
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT05883540
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Lysergic Acid Diethylamide (LSD) in Palliative Care?
This study is exploring observational follow-up for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by University Hospital, Basel, Switzerland. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me